Astrocytic modulation of neuronal signalling

SS Purushotham, Y Buskila - Frontiers in Network Physiology, 2023 - frontiersin.org
Neuronal signalling is a key element in neuronal communication and is essential for the
proper functioning of the CNS. Astrocytes, the most prominent glia in the brain play a key …

Brain clearance of protein aggregates: a close-up on astrocytes

V Giusti, G Kaur, E Giusto, L Civiero - Molecular Neurodegeneration, 2024 - Springer
Protein misfolding and accumulation defines a prevailing feature of many
neurodegenerative disorders, finally resulting in the formation of toxic intra-and extracellular …

Preclinical quality, safety, and efficacy of a human embryonic stem cell-derived product for the treatment of Parkinson's disease, STEM-PD

A Kirkeby, J Nelander, DB Hoban, N Rogelius… - Cell Stem Cell, 2023 - cell.com
Cell replacement therapies for Parkinson's disease (PD) based on transplantation of
pluripotent stem cell-derived dopaminergic neurons are now entering clinical trials. Here, we …

[HTML][HTML] Calcium deregulation in neurodegeneration and neuroinflammation in Parkinson's Disease: Role of calcium-storing organelles and sodium–calcium …

G Bastioli, S Piccirillo, L Graciotti, M Carone, G Sprega… - Cells, 2024 - mdpi.com
Parkinson's disease (PD) is a progressive neurodegenerative disorder that lacks effective
treatment strategies to halt or delay its progression. The homeostasis of Ca2+ ions is crucial …

Revolutionizing neurocare: biomimetic nanodelivery via cell membranes

J Liao, L Gong, Q Xu, J Wang, Y Yang… - Advanced …, 2024 - Wiley Online Library
Brain disorders represent a significant challenge in medical science due to the formidable
blood–brain barrier (BBB), which severely limits the penetration of conventional …

Propagation of pathologic α-synuclein from kidney to brain may contribute to Parkinson's disease

X Yuan, S Nie, Y Yang, C Liu, D Xia, L Meng… - Nature …, 2025 - nature.com
The pathogenesis of Lewy body diseases (LBDs), including Parkinson's disease (PD),
involves α-synuclein (α-Syn) aggregation that originates in peripheral organs and spreads to …

Modulating α-synuclein propagation and decomposition: implications in Parkinson's disease therapy

B Li, X Xiao, M Bi, Q Jiao, X Chen, C Yan, X Du… - Ageing Research …, 2024 - Elsevier
Abstract α-Synuclein (α-Syn) is closely related to the pathogenesis of Parkinson's disease
(PD). Under pathological conditions, the conformation of α-syn changes and different forms …

Glial senescence enhances α-synuclein pathology owing to its insufficient clearance caused by autophagy dysfunction

B Hong, Y Ohtake, T Itokazu, T Yamashita - Cell death discovery, 2024 - nature.com
Parkinson's disease (PD) is characterized by the pathological accumulation of α-synuclein
(α-syn) and loss of dopaminergic neurons in the substantia nigra. Aging is a significant risk …

Heteromerization of dopamine D2 and oxytocin receptor in adult striatal astrocytes

S Amato, M Averna, D Guidolin, C Ceccoli… - International Journal of …, 2023 - mdpi.com
The ability of oxytocin (OT) to interact with the dopaminergic system through facilitatory D2-
OT receptor (OTR) receptor-receptor interaction in the limbic system is increasingly …

Neuroinflammation, immune response and α-synuclein pathology: how animal models are helping us to connect dots

T Balzano, N Esteban-García… - Expert Opinion on Drug …, 2023 - Taylor & Francis
Introduction A key pathological event occurring in Parkinson's disease (PD) is the
transneuronal spreading of alpha-synuclein (α-syn). Other hallmarks of PD include …